All Available Technologies
The invention is a novel adaptive aero structure based on conventional, certified aerospace materials.
The invention provides novel compounds (adjuvants) that can be used as agonists for Toll-Like Receptor 7 (TLR7). By specifically targeting TLR7, these adjuvants elicit a type 1 interferon response which is essential in the development of antiviral responses.
KU research on the brain activity associated with low back pain led to the invention of a simple and cost-effective device that can be used to induce stimulation to a person's back during an fMRI scanning procedure.
The invention covers novel macrocyclic peptides for treating pain through stimulation of opioid receptors that does not cause addiction.
KU researchers in Dr. Judy Wu's lab have developed a novel process for large-area graphene growth directly on non-metal substrate templates.
Novel Cyclophilin D inhibitors to treat Alzheimer's and other neurodegenerative diseases.
This invention comprises of an aircraft that is capable of both sustained out-of-ground effect hover flight and sustained supersonic flight
This invention comprises of an apparatus and method for adaptive materials that are arranged in a variety of orientations and with a wide range of attachment configurations that induce structural vibrations at extremely high frequencies.
This invention provides a computationally efficient means of performing adaptive pulse compression (APC) and is denoted as the Fast APC (FAPC) algorithm. The FAPC algorithm dramatically reduces range sidelobes while maintaining near optimal signal-to-noise (SNR) gain and is much more computationally efficient than the original APC.
A novel method of inducing adult-derived stem cell proliferation in tissue from adult animals. Harvested embryonic, pluripotent or more differentiated stem cells may be used in cell therapy, tissue engineering, or other medical, veterinary, and industrial applications.